Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosbretabulin in Asian Subjects With PCV
NCT01023295Phase 2Completed
- Sponsor
- Oncotelic Therapeutics, Inc.
- Start
- Jul 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of fosbretabulin in polypoidal choroidal vasculopathy (PCV), sponsored by Oncotelic Therapeutics, Inc.. Started Jul 2009; status: completed.
02
Drugs
fosbretabulin
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT01023295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01023295.